This thesis comprehensively examines the role of International Council for Harmonisation guidelines in harmonizing pharmaceutical regulatory requirements across global jurisdictions. Through systematic analysis of seventy-three ICH guidelines and their implementation across twenty countries, this research evaluates harmonization patterns, impacts on pharmaceutical development, and effects on patient access to medicines. The study employs mixed-methods including documentary analysis, comparative regulatory assessment, and statistical evaluation of development timelines and approval processes spanning 1990-2025.